Novonesis A/S

BRSE:NZYMB Stock Report

Market Cap: CHF 24.1b

Novonesis Past Earnings Performance

Past criteria checks 0/6

Novonesis's earnings have been declining at an average annual rate of -1.3%, while the Chemicals industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 8.1% per year. Novonesis's return on equity is 2.6%, and it has net margins of 9.3%.

Key information

-1.3%

Earnings growth rate

-0.6%

EPS growth rate

Chemicals Industry Growth6.0%
Revenue growth rate8.1%
Return on equity2.6%
Net Margin9.3%
Next Earnings Update26 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Novonesis makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BRSE:NZYMB Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 243,045283575326
31 Mar 242,696332506298
31 Dec 232,401406446271
30 Sep 232,390430441270
30 Jun 232,382460446272
31 Mar 232,390487441270
31 Dec 222,360494430267
30 Sep 222,268460443262
30 Jun 222,186418418257
31 Mar 222,090416403257
31 Dec 212,009423380266
30 Sep 211,958427335268
30 Jun 211,914409322274
31 Mar 211,883389310270
31 Dec 201,883380309256
30 Sep 201,920415309248
30 Jun 201,955405326254
31 Mar 201,968439335264
31 Dec 191,924422329263
30 Sep 191,923411334262
30 Jun 191,917434321260
31 Mar 191,922417315249
31 Dec 181,927432313248
30 Sep 181,924427311254
30 Jun 181,915429310247
31 Mar 181,920423320248
31 Dec 171,952419332255
30 Sep 171,958421334255
30 Jun 171,934412332254
31 Mar 171,919414328251
31 Dec 161,902410325251
30 Sep 161,864394327247
30 Jun 161,883394333253
31 Mar 161,883384331259
31 Dec 151,876378330254
30 Sep 151,840366320255
30 Jun 151,795353314252
31 Mar 151,741340311243
31 Dec 141,673339306237
30 Sep 141,641334314227
30 Jun 141,605324310216
31 Mar 141,598319312211
31 Dec 131,575295311205

Quality Earnings: NZYMB has a large one-off loss of €105.1M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: NZYMB's current net profit margins (9.3%) are lower than last year (19.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: NZYMB's earnings have declined by 1.3% per year over the past 5 years.

Accelerating Growth: NZYMB's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NZYMB had negative earnings growth (-38.5%) over the past year, making it difficult to compare to the Chemicals industry average (-8.1%).

Return on Equity

High ROE: NZYMB's Return on Equity (2.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/27 22:21
End of Day Share Price 2024/08/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Novonesis A/S is covered by 40 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael Vitfell-RasmussenABG Sundal Collier
Jyoti PrakashAlphaValue
Carla BänzigerBank Vontobel AG